Fig 1.
Flow chart of patient disposition.
Table 1.
Demographic and baseline patient characteristics.
Fig 2.
Efficacy outcome: Analysis of 100-mm pain VAS.
A. Efficacy outcome: analysis of 100-mm pain VAS at week 2, 4 _ change of 100mm Pain VAS (PP). B. Efficacy outcome: analysis of 100-mm pain VAS at week 2, 4 _ change of 100mm Pain VAS (FA).
Table 2.
Primary efficacy outcome: Analysis of 100-mm pain VAS at week 4 (PP and FA sets).
Table 3.
Primary efficacy outcome: analysis (adding site factor) of 100-mm pain VAS at week 4 (PP and FA sets).
Table 4.
Analyses of secondary efficacy outcomes (PP set): 100-mm pain VAS at week 2 and K-WOMAC scores.
Table 5.
Analyses of secondary efficacy outcomes (FA set): 100-mm pain VAS at week 2 and K-WOMAC scores.
Table 6.
Secondary efficacy outcomes: patient global assessment and use of rescue medicine (PP and FA sets).
Table 7.
Adverse events during the study (safety set).